dc.contributor.author | Valuckaitė, Rytė | |
dc.contributor.author | Šimienė, Julija | |
dc.contributor.author | Strainienė, Eglė | |
dc.contributor.author | Stankevičius, Vaidotas | |
dc.contributor.author | Ušinskienė, Jurgita | |
dc.contributor.author | Mišeikytė Kaubrienė, Edita | |
dc.contributor.author | Lagunavičienė, Ingrida | |
dc.contributor.author | Cicėnas, Jonas | |
dc.contributor.author | Sužiedėlis, Kęstutis | |
dc.date.accessioned | 2023-09-18T20:50:52Z | |
dc.date.available | 2023-09-18T20:50:52Z | |
dc.date.issued | 2019 | |
dc.identifier.issn | 2072-6694 | |
dc.identifier.uri | https://etalpykla.vilniustech.lt/handle/123456789/152955 | |
dc.description.abstract | Glioma is the most aggressive brain tumor of the central nervous system. The ability of glioma cells to migrate, rapidly diffuse and invade normal adjacent tissue, their sustained proliferation, and heterogeneity contribute to an overall survival of approximately 15 months for most patients with high grade glioma. Numerous studies indicate that non-coding RNA species have critical functions across biological processes that regulate glioma initiation and progression. Recently, new data emerged, which shows that the cross-regulation between long non-coding RNAs and small non-coding RNAs contribute to phenotypic diversity of glioblastoma subclasses. In this paper, we review data of long non-coding RNA expression, which was evaluated in human glioma tissue samples during a five-year period. Thus, this review summarizes the following: (I) the role of non-coding RNAs in glioblastoma pathogenesis, (II) the potential application of non-coding RNA species in glioma-grading, (III) crosstalk between lncRNAs and miRNAs (IV) future perspectives of non-coding RNAs as biomarkers for glioma. | eng |
dc.format | PDF | |
dc.format.extent | p. 1-35 | |
dc.format.medium | tekstas / txt | |
dc.language.iso | eng | |
dc.relation.isreferencedby | DOAJ | |
dc.relation.isreferencedby | Embase | |
dc.relation.isreferencedby | CAB Abstracts | |
dc.relation.isreferencedby | Scopus | |
dc.relation.isreferencedby | Science Citation Index Expanded (Web of Science) | |
dc.source.uri | https://doi.org/10.3390/cancers11010017 | |
dc.title | Non-coding RNAs in glioma | |
dc.type | Straipsnis Web of Science DB / Article in Web of Science DB | |
dcterms.references | 250 | |
dc.type.pubtype | S1 - Straipsnis Web of Science DB / Web of Science DB article | |
dc.contributor.institution | Nacionalinis vėžio institutas | |
dc.contributor.institution | Nacionalinis vėžio institutas Vilniaus universitetas | |
dc.contributor.institution | Vilniaus Gedimino technikos universitetas Nacionalinis vėžio institutas | |
dc.contributor.institution | Vilniaus universitetas MAP Kinase Resource | |
dc.contributor.institution | Vilniaus universitetas MAP Kinase Resource Aleksandro Stulginskio universitetas | |
dc.contributor.faculty | Fundamentinių mokslų fakultetas / Faculty of Fundamental Sciences | |
dc.subject.researchfield | T 005 - Chemijos inžinerija / Chemical engineering | |
dc.subject.researchfield | M 001 - Medicina / Medicine | |
dc.subject.researchfield | N 010 - Biologija / Biology | |
dc.subject.vgtuprioritizedfields | FM0202 - Ląstelių ir jų biologiškai aktyvių komponentų tyrimai / Investigations on cells and their biologically active components | |
dc.subject.ltspecializations | L105 - Sveikatos technologijos ir biotechnologijos / Health technologies and biotechnologies | |
dc.subject.en | non-coding RNA | |
dc.subject.en | glioma | |
dc.subject.en | miRNA | |
dc.subject.en | lncRNA | |
dcterms.sourcetitle | Cancers | |
dc.description.issue | iss. 1 | |
dc.description.volume | vol. 11 | |
dc.publisher.name | MDPI | |
dc.publisher.city | Basel | |
dc.identifier.doi | 000457240200016 | |
dc.identifier.doi | 2-s2.0-85061932089 | |
dc.identifier.doi | 10.3390/cancers11010017 | |
dc.identifier.elaba | 34529897 | |